Entity Details

Primary name ENPP1
Entity type gene
Source Source Link

Details

PrimaryID5167
RefseqGeneNG_008206
SymbolENPP1
Nameectonucleotide pyrophosphatase/phosphodiesterase 1
Chromosome6
Location6q23.2
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2000-08-24
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsENPP1_HUMAN

GO terms

Show/Hide Table
GOName
GO:0003676 nucleic acid binding
GO:0004527 exonuclease activity
GO:0004528 phosphodiesterase I activity
GO:0004551 nucleotide diphosphatase activity
GO:0005044 scavenger receptor activity
GO:0005158 insulin receptor binding
GO:0005509 calcium ion binding
GO:0005524 ATP binding
GO:0005615 extracellular space
GO:0005765 lysosomal membrane
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006091 generation of precursor metabolites and energy
GO:0006771 riboflavin metabolic process
GO:0006796 phosphate-containing compound metabolic process
GO:0006955 immune response
GO:0008270 zinc ion binding
GO:0009143 nucleoside triphosphate catabolic process
GO:0009986 cell surface
GO:0016021 integral component of membrane
GO:0016323 basolateral plasma membrane
GO:0030247 polysaccharide binding
GO:0030308 negative regulation of cell growth
GO:0030318 melanocyte differentiation
GO:0030500 regulation of bone mineralization
GO:0030502 negative regulation of bone mineralization
GO:0030505 inorganic diphosphate transport
GO:0030643 cellular phosphate ion homeostasis
GO:0030730 sequestering of triglyceride
GO:0031214 biomineral tissue development
GO:0031953 negative regulation of protein autophosphorylation
GO:0032869 cellular response to insulin stimulus
GO:0035529 NADH pyrophosphatase activity
GO:0036218 dTTP diphosphatase activity
GO:0042803 protein homodimerization activity
GO:0045599 negative regulation of fat cell differentiation
GO:0045719 negative regulation of glycogen biosynthetic process
GO:0046034 ATP metabolic process
GO:0046325 negative regulation of glucose import
GO:0046627 negative regulation of insulin receptor signaling pathway
GO:0047429 nucleoside-triphosphate diphosphatase activity
GO:0050427 3'-phosphoadenosine 5'-phosphosulfate metabolic process
GO:0050656 3'-phosphoadenosine 5'-phosphosulfate binding
GO:0090305 nucleic acid phosphodiester bond hydrolysis
GO:0106177 cyclic-GMP-AMP hydrolase activity
GO:1990787 negative regulation of hh target transcription factor activity

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615522 OMIMCole disease (COLED)A rare autosomal dominant genodermatosis characterized by punctate keratoderma associated with irregularly shaped hypopigmented macules, which are typically found over the arms and legs but not the trunk or acral regions. Skin biopsies of palmoplantar lesions show hyperorthokeratosis, hypergranulosis, and acanthosis. Hypopigmented areas of skin, however, reveal a reduction in melanin content in keratinocytes but not in melanocytes, as well as hyperkeratosis and a normal number of melanocytes. Ultrastructurally, melanocytes show a disproportionately large number of melanosomes in the cytoplasm and dendrites, whereas keratinocytes show a paucity of these organelles, suggestive of impaired melanosome transfer. Some patients also exhibit calcinosis cutis or calcific tendinopathy. The disease is caused by variants affecting the gene represented in this entry.
602475 OMIMOssification of the posterior longitudinal ligament of the spine (OPLL)A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. Patients with OPLL frequently present with a severe myelopathy that can lead to tetraparesis. The disease is caused by variants affecting the gene represented in this entry.
208000 OMIMArterial calcification of infancy, generalized, 1 (GACI1)A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. The disease is caused by variants affecting the gene represented in this entry.
613312 OMIMHypophosphatemic rickets, autosomal recessive, 2 (ARHR2)A hereditary form of hypophosphatemic rickets, a disorder of proximal renal tubule function that causes phosphate loss, hypophosphatemia and skeletal deformities, including rickets and osteomalacia unresponsive to vitamin D. Symptoms are bone pain, fractures and growth abnormalities. The disease is caused by variants affecting the gene represented in this entry.
125853 OMIMDiabetes mellitus, non-insulin-dependent (NIDDM)A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. Disease susceptibility is associated with variants affecting the gene represented in this entry.